NF1 and malignant peripheral nerve sheath tumor: An early-phase neoadjuvant study (NCT04465643) is evaluating the safety and feasibility of administering nivolumab plus ipilimumab prior to surgical resection of NF1-associated atypical neurofibromas and MPNST (Table 1).